K.J. Harrison & Partners’s Eli Lilly LLY Stock Holding History

K.J. Harrison & Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.8M	Sell	3,042 -3,000	-50%	-$3.04M	0.46%	58
2025 Q4	$6.49M	Sell	6,042 -3,650	-38%	-$3.49M	0.86%	28
2025 Q3	$7.95M	Buy	9,692 +4,110	+74%	+$3.06M	1.14%	18
2025 Q2	$4.35M	Sell	5,582 -898	-14%	-$698K	0.72%	43
2025 Q1	$5.35M	Sell	6,480 -2,063	-24%	-$1.72M	1.05%	24
2024 Q4	$6.65M	Buy	8,543 +144	+2%	+$119K	1.04%	25
2024 Q3	$7.61M	Sell	8,399 -993	-11%	-$893K	1.15%	21
2024 Q2	$8.5M	Sell	9,392 -106	-1%	-$84.8K	1.4%	19
2024 Q1	$7.39M	Buy	9,498 +3,794	+67%	+$2.7M	1.14%	25
2023 Q4	$3.32M	Buy	+5,704	New	+$3.33M	0.56%	53
2023 Q3	–	Sell	-3,048	Closed	-$1.42M	–	165
2023 Q2	$1.42M	Buy	3,048 +2,018	+196%	+$846K	0.26%	106
2023 Q1	$354K	Sell	1,030 -30	-3%	-$10.1K	0.07%	177
2022 Q4	$525K	Sell	1,060 -40	-4%	-$14.2K	0.1%	158
2022 Q3	$356K	Buy	1,100 +100	+10%	+$31.7K	0.13%	123
2022 Q2	$325K	Buy	+1,000	New	+$300K	0.09%	144

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

K.J. Harrison & Partners's LLY Position: Q1 2026 in Review

K.J. Harrison & Partners reduced its Eli Lilly (LLY) stake by 50% in Q1 2026, selling an estimated $3.04M and leaving 3,042 shares worth $2.8M. The position accounts for 0.46% of the portfolio, ranked #58.

K.J. Harrison & Partners first reported a position in LLY in Q2 2022 and has held it in 15 quarters since. The position peaked at $8.5M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

K.J. Harrison & Partners held 3,042 shares of Eli Lilly worth $2.8M as of Q1 2026.
K.J. Harrison & Partners sold 3,000 Eli Lilly shares in Q1 2026, an estimated $3.04M.
Eli Lilly made up 0.46% of K.J. Harrison & Partners's portfolio in Q1 2026, its #58 holding.
K.J. Harrison & Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 15 quarters since.
K.J. Harrison & Partners's Eli Lilly position peaked at $8.5M in Q2 2024.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.